| |
|
|
ANDOVER, MASS. - Tokyo, Japan-based drugmaker Eisai Co. is planning to begin construction in early 2004 on a $65-million R&D center in Andover, Mass. The facility will enable Eisai to double its U.S. basic research staff to as many as 170 employees. Eisai will also spend approximately $9-million on a second production line for drugs used in clinical testing at one of its existing U.S. research facilities.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more!
Sign Up Now!
|
|